Luceome Biotechnologies Receives $1.9 Million in Phase I and Phase II SBIR Funding

>>Luceome Biotechnologies Receives $1.9 Million in Phase I and Phase II SBIR Funding

TUCSON, AZ – LUCEOME BIOTECHNOLOGIES a privately held biotechnology company focused on the discovery and development of its innovative proprietary assay platform today announced the award of $1.6 million in grant funding from The National Institutes of Health to further their research in high throughput screening using the KinaseSeeker™ technology. Earlier this year, Luceome was awarded a grant for $287K for research in the area of poly(ADP-ribose) detection.

Read More

2016-10-03T22:50:48+00:00October 3rd, 2016|In The News|